menu
    • menu

    Company profile for NImmune Biopharma

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NImmune is a late-stage precision immunology biopharmaceutical company that develops best-in-class biomarker-driven immunoregulatory therapeutics. Underpinned by advanced computational modeling and bioinformatics coupled with biomedical research capabilities to pioneer innovation in immunoregulatory drug development, NImmune’s business model enables the rapid and capital-efficient clinical development of high conviction drug...
    NImmune is a late-stage precision immunology biopharmaceutical company that develops best-in-class biomarker-driven immunoregulatory therapeutics. Underpinned by advanced computational modeling and bioinformatics coupled with biomedical research capabilities to pioneer innovation in immunoregulatory drug development, NImmune’s business model enables the rapid and capital-efficient clinical development of high conviction drug candidates into New Drug Application (NDA) filing and commercialization.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NImmune BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1800 Kraft Dr Ste 100 Blacksburg, VA 24060
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nimmunebio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nimmune-biopharma-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NImmune to Present Mechanistic on LANCL2-Targeting Therapeutics
    NImmune to Present Mechanistic on LANCL2-Targeting Therapeutics

    24 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260324351143/en/NImmune-Biopharma-to-Present-Novel-Mechanistic-Efficacy-and-Translational-Data-on-LANCL2-Targeting-Therapeutics-Supporting-Significant-Pipeline-in-a-Drug-Potential-at-IMMUNOLOGY2026

    BUSINESSWIRE
    24 Mar 2026
    Share Share
    NIM-1324 Program Launched for UC and Crohn’s Disease
    NIM-1324 Program Launched for UC and Crohn’s Disease

    17 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260217742112/en/Leading-the-Next-Wave-of-Innovative-IBD-Therapeutics-Targeting-Immunometabolism-Josep-Bassaganya-Riera-Launches-Clinical-Program-and-Business-Venture-to-Develop-NIM-1324-for-Ulcerative-Colitis-and-Crohns-disease

    BUSINESSWIRE
    17 Feb 2026
    Share Share
    NImmune To Present Omilancor Data Showing Superiority
    NImmune To Present Omilancor Data Showing Superiority

    06 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250506018915/en/NImmune-Biopharma-to-Present-at-DDW25-the-First-Ever-Head-to-Head-Clinical-and-Translational-Results-for-Omilancor-Versus-Leading-Anti-TL1A-in-IBD-Showing-Superiority-and-Complementarity

    BUSINESSWIRE
    06 May 2025
    Share Share
    NIMML & NImmune Show How TITAN-X A.I. Accelerates Therapy
    NIMML & NImmune Show How TITAN-X A.I. Accelerates Therapy

    21 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250421323133/en/The-NIMML-Institute-and-NImmune-Biopharma-Showcase-How-the-TITAN-X-A.I.-Platform-has-Accelerated-Therapeutic-Development-in-the-Annual-Review-of-Biomedical-Data-Science

    BUSINESSWIRE
    21 Apr 2025
    Share Share
    NImmune Positive Ph 2 Data for Systemic Lupus Erythematosus
    NImmune Positive Ph 2 Data for Systemic Lupus Erythematosus

    13 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250113405332/en

    BUSINESSWIRE
    13 Jan 2025
    Share Share
    NImmune Biopharma Acquires Omilancor Rights in Asia
    NImmune Biopharma Acquires Omilancor Rights in Asia

    23 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241023953586/en

    BUSINESSWIRE
    23 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search